Ameratunga R, McKee J, French J, Prestidge R, Fanslow W, Marbrook J
Department of Molecular Medicine, University of Auckland, New Zealand.
Clin Diagn Lab Immunol. 1996 Nov;3(6):722-6. doi: 10.1128/cdli.3.6.722-726.1996.
The X-linked hyper-immunoglobulin M syndrome (XHIM) is a primary immune deficiency disorder characterized by an inability to produce immunoglobulin isotypes other than immunoglobulin M (IgM) and IgD. Recently, a B-cell surface antigen (CD40) and its conjugate T-cell counterstructure (CD40 ligand) were shown to mediate immunoglobulin isotype switching in the presence of cytokines such as interleukin 4. Most patients with XHIM have been shown to have mutations of the extracellular domain of the CD40 ligand. Here we describe a novel point mutation of an intronic splice acceptor site which results in a complex splicing defect of the CD40 ligand in a patient with XHIM. In addition to two species of deleted transcripts, wild-type transcripts were also detected in this individual. The demonstration of wild-type CD40 ligand transcripts may be an explanation for previous observations suggesting that some XHIM patients are able to undergo immunoglobulin isotype switching in vivo.
X连锁高免疫球蛋白M综合征(XHIM)是一种原发性免疫缺陷病,其特征是无法产生除免疫球蛋白M(IgM)和IgD之外的免疫球蛋白同种型。最近,一种B细胞表面抗原(CD40)及其共轭T细胞对应结构(CD40配体)被证明在白细胞介素4等细胞因子存在的情况下介导免疫球蛋白同种型转换。大多数XHIM患者已被证明存在CD40配体细胞外结构域的突变。在此,我们描述了一名XHIM患者内含子剪接受体位点的一种新型点突变,该突变导致CD40配体出现复杂的剪接缺陷。除了两种缺失的转录本外,在该个体中还检测到野生型转录本。野生型CD40配体转录本的发现可能解释了先前的观察结果,即一些XHIM患者能够在体内进行免疫球蛋白同种型转换。